Advertisement

Documenta Ophthalmologica

, Volume 135, Issue 3, pp 241–248 | Cite as

Electrophysiological features and multimodal imaging in ritonavir-related maculopathy

  • Céline Faure
  • Michel Paques
  • Isabelle Audo
Clinical Case Report

Abstract

Purpose

The purpose of this study is to report a case of ritonavir-related retinal toxicity followed over a year. Electrophysiological features and multimodal imaging, including adaptive optics, are provided and discussed.

Methods

Electrophysiological recordings and multimodal imaging were performed and repeated over 1 year.

Results

Fundus examination revealed crystalline maculopathy in conjunction with pigment disruption. Spectral domain optical coherence tomography displayed thinning of the macula without cysts. Autofluorescence imaging revealed a mixed pattern of complete loss of the autofluorescence in the area of retinal pigment deposit and an increased transmission of the autofluorescence in the area of retinal thinning. Fluorescein angiography ruled out parafoveal telangiectasia. Indocyanine green angiography was not contributive. Increased spacing of the macular cone mosaic, crystal deposits and pigment migrations were seen with adaptive optics. Full-field electroretinogram was slightly reduced for both eyes, especially in the light-adapted responses, and mfERG confirmed bilateral maculopathy. Functional and structural abnormalities did not change with follow-up besides constant pigmentary changes monitored with adaptive optics.

Conclusion

Ritonavir-related retinal toxicity is a maculopathy with peculiar features including crystalline and pigment migration associated with central or temporofoveolar thinning and inconstant macular telangiectasia. Despite drug cessation, retinal remodelling continues to progress.

Keywords

Ritonavir maculopathy Crystalline maculopathy Toxic maculopathy Phospholipidosis 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Statement of human rights

All procedures performed in this study involving our human participant were in accordance with the ethical standards of the institutional and / or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Statement on the welfare of animals

This article does not contain any studies with animals performed by any of the authors.

Patient consent

The patient has consented to the submission of the manuscript for this journal.

Supplementary material

Movie 1

Time-lapse AO movie showing the redistribution of melanosomes inside melanin-loaded cells (MP4 931 kb). The migration of th melanin pigments suggest a continuous process of remodelling of the scar tissue

References

  1. 1.
    Roe RH, Jumper JM, Gualino V, Wender J, McDonald HR, Johnson RN, Fu AD, Cunningham ET Jr (2011) Retinal pigment epitheliopathy, macular telangiectasis, and intraretinal crystal deposits in HIV-positive patients receiving ritonavir. Retina 31:559–565CrossRefPubMedGoogle Scholar
  2. 2.
    Leiner S (2012) Re: retinal pigment epitheliopathy, macular telangiectasis, and intraretinal crystal deposits in HIV-positive patients receiving ritonavir. Retina 32(2):411CrossRefPubMedGoogle Scholar
  3. 3.
    European Medicines Agency. Scientific discussion for the approval of Norvir. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_Scientific_Discussion/human/000127/WC500028725.pdf
  4. 4.
    McCulloch DL, Marmor MF, Brigell MG, Hamilton R, Holder GE, Tzekov R, Bach M (2015) ISCEV Standard for full-field clinical electroretinography (2015 update). Doc Ophthalmol 130(1):1–12CrossRefPubMedGoogle Scholar
  5. 5.
    Biancardi AL, Curi ALL (2016) Retinal toxicity related to long-term use of ritonavir. Retina 36:229–231CrossRefPubMedGoogle Scholar
  6. 6.
    Anderson N, Borlak J (2006) Drug-induced phospholipidosis. FEBS Lett 580(23):5533–5540CrossRefPubMedGoogle Scholar
  7. 7.
    Gocho K, Sarda V, Falah S, Sahel JA, Sennlaub F, Benchaboune M, Ullern M, Paques M (2013) Adaptive optics imaging of geographic atrophy. Invest Ophthalmol Vis Sci 54:3673–3680CrossRefPubMedGoogle Scholar
  8. 8.
    Fawzi AA, Lee NG, Eliott D, Song J, Stewart JM (2009) Retinal findings in patients with Alport Syndrome: expanding the clinical spectrum. Br J Ophthalmol 93(12):1606–1611CrossRefPubMedGoogle Scholar
  9. 9.
    Vadlapatla RK, Vadlapudi AD, Pal D, Mukherji M, Mitra AK (2014) Ritonavir inhibits HIF-1α-mediated VEGF expression in retinal pigment epithelial cells in vitro. Eye (Lond) 28(1):93–101CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany 2017

Authors and Affiliations

  1. 1.Unité d’électrophysiologieCentre hospitalier national d’ophtalmologie des Quinze-VingtsParisFrance
  2. 2.Ramsay Générale de santé, Hôpital Privé Saint MartinCaenFrance
  3. 3.INSERM U968, CNRS, UMR 7210, Institut de la VisionSorbonne Universités, UPMC Univ Paris 06ParisFrance
  4. 4.Département hospitalo-universitaire ViewMaintain, Inserm-Direction de l’hospitalisation et de l’organisation des soins-Centre d’Investigations cliniques (DHOS CIC) 1423Centre hospitalier national d’ophtalmologie des Quinze-VingtsParisFrance

Personalised recommendations